District of Columbia: Zantac (ranitidine… | DrugsMonitor.com

Zantac (ranitidine) litigation in District of Columbia (DC): MDL-linked practice notes, filing-deadline context, confidential review—not legal advice.

NDMA, ranitidine, recalled heartburn medication, cancer allegations, District of Columbia